Matthew Pauls Insider Trading $EGLT Zyla Life Sciences

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew Pauls.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew Pauls. Matthew Pauls is CHIEF EXECUTIVE OFFICER in Savara Inc ($SVRA) and Director in Mast Therapeutics, Inc. ($MSTX) and See Remarks in Savara Inc ($SVRA) and Director in Egalet Corp ($EGLT) and President & CEO in Strongbridge Biopharma plc ($SBBP).

Matthew Pauls in Zyla Life Sciences

Trading Symbol: EGLT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Pauls: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 21 2020
$EGLT Market Capitalization: $112.49M
$EGLT Previous Close: $4.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Matthew Pauls in Zyla Life Sciences

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, SVRA, SBBP, EGLT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 21 2020EGLTZyla Life SciencesPauls MatthewDirectorSellD0.0026,9530027 K to 0 (-100.00 %)
Apr 24 2020EGLTZyla Life SciencesPauls MatthewDirectorOption ExerciseM0.006,667013,333
Apr 24 2020EGLTZyla Life SciencesPauls MatthewDirectorPayment of ExerciseF1.759521,6665,7156.7 K to 5.7 K (-14.28 %)
Apr 24 2020EGLTZyla Life SciencesPauls MatthewDirectorBuyM1.756,66711,6676,6670 to 6.7 K
Mar 05 2020EGLTZyla Life SciencesPauls MatthewDirectorGrantA0.0013,620013,6200 to 13.6 K
Apr 24 2019EGLTEgalet CorpPauls MatthewDirectorGrantA0.0020,000020,0000 to 20 K

Page:   1